ES2078215T3 - 1,4-dihidropiridinas. - Google Patents

1,4-dihidropiridinas.

Info

Publication number
ES2078215T3
ES2078215T3 ES87300785T ES87300785T ES2078215T3 ES 2078215 T3 ES2078215 T3 ES 2078215T3 ES 87300785 T ES87300785 T ES 87300785T ES 87300785 T ES87300785 T ES 87300785T ES 2078215 T3 ES2078215 T3 ES 2078215T3
Authority
ES
Spain
Prior art keywords
optionally substituted
sub
formula
represent
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87300785T
Other languages
English (en)
Inventor
John Leheup Archibald
Terence James Ward
Albert Opalko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Application granted granted Critical
Publication of ES2078215T3 publication Critical patent/ES2078215T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I) O SALES DE LOS MISMOS, DONDE: ALFA Y BETA JUNTOS REPRESENTAN UN ENLACE Y ADEMAS, SI B ES UN GRUPO CAPTOR DE ELECTRONES, ALFA PUEDE REPRESENTAR TAMBIEN OH Y BETA PUEDE REPRESENTAR HIDROGENO; AR ES UN RADICAL ARILO OPCIONALMENTE SUSTITUIDO, R REPRESENTA HIDROGENO O UN GRUPO ALQUILO O ARILALQUILO OPCIONALMENTE SUSTITUIDO, R1 Y R2 SON IGUALES O DISTINTOS Y SE SELECCIONAN ENTRE HIDROGENO Y DISTINTOS RADICALES DE HIDROCARBUROS ALIFATICOS CICLICOS O ACICLICOS, SATURADOS O NO SATURADOS, SUSTITUIDOS OPCIONALMENTE CON UNO O VARIOS DE LOS GRUPOS SELECCIONADOS ENTRE HALOGENO, OH, CARBOXI, CN, ALCOXI, ALQUILTIO, ARILOXI, AMINO, AMINO SUSTITUIDO Y ARILO SUSTITUIDO; A REPRESENTA UN GRUPO DE FORMULA -XR3 DONDE X ES UN GRUPO DE FORMULA -(CHR6)P-Y-(CHR7)Q- EN LA CUAL Y REPRESENTA -O-, -S-, NR8 O UN ENLACE DIRECTO, P Y Q REPRESENTAN, CADA UNO, 0,1 O 2, R7 Y R8 REPRESENTAN INDEPENDIENTEMENTE HIDROGENO O ALQUILO INFERIOR Y R3 ES UN RADICAL HETEROARILICO NITROGENADO, OPCIONALMENTE SUSTITUIDO, QUE PUEDE CONTENER OPCIONALMENTE EN EL ANILLO OTROS HETEROATOMOS SELECCIONADOS ENTRE O,N O S; B REPRESENTA HALOALQUILO, FENILO OPCIONALMENTE SUSTITUIDO, -CN, -CHO, CH(ALQUILO INFERIOR)2 O CH2OH.
ES87300785T 1986-02-01 1987-01-29 1,4-dihidropiridinas. Expired - Lifetime ES2078215T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868602518A GB8602518D0 (en) 1986-02-01 1986-02-01 1 4-dihydropyridines

Publications (1)

Publication Number Publication Date
ES2078215T3 true ES2078215T3 (es) 1995-12-16

Family

ID=10592383

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87300785T Expired - Lifetime ES2078215T3 (es) 1986-02-01 1987-01-29 1,4-dihidropiridinas.

Country Status (12)

Country Link
US (1) US5064842A (es)
EP (1) EP0233015B1 (es)
JP (1) JPH0723370B2 (es)
KR (1) KR950003922B1 (es)
AT (1) ATE129242T1 (es)
CA (1) CA1329600C (es)
DE (1) DE3751562T2 (es)
ES (1) ES2078215T3 (es)
GB (2) GB8602518D0 (es)
GR (1) GR3018729T3 (es)
HU (1) HU199139B (es)
PT (1) PT84206B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2036128B1 (es) * 1991-07-10 1993-12-16 Menarini Lab Procedimiento para la preparacion de 4-(imidazo)1,5-a)piridin-8l)-1,4-dihidropiridinas.
US5288866A (en) * 1991-12-20 1994-02-22 American Cyanamid Company 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5- (substituted methyl)-2,3-pyridinedicarboxylic acids

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2738153A1 (de) * 1977-08-24 1979-03-08 Bayer Ag 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
EP0100189B1 (en) * 1982-07-22 1986-05-28 Pfizer Limited Dihydropyridine anti-ischaemic and antihypertensive agents
US4607041A (en) * 1983-04-27 1986-08-19 Fisons Plc Antihypertensive 2-phenyl Hantzsch dihydropyridines
GR851819B (es) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
EP0174131A3 (en) * 1984-09-01 1989-06-07 FISONS plc Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them
EP0225175A3 (en) * 1985-11-28 1988-12-28 FISONS plc Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
EP0233015A3 (en) 1990-11-07
HUT45988A (en) 1988-09-28
EP0233015A2 (en) 1987-08-19
DE3751562D1 (de) 1995-11-23
US5064842A (en) 1991-11-12
PT84206B (pt) 1989-11-30
EP0233015B1 (en) 1995-10-18
GB8702016D0 (en) 1987-03-04
CA1329600C (en) 1994-05-17
PT84206A (en) 1987-02-01
HU199139B (en) 1990-01-29
KR950003922B1 (ko) 1995-04-20
JPS62201868A (ja) 1987-09-05
GB2185982A (en) 1987-08-05
GR3018729T3 (en) 1996-04-30
DE3751562T2 (de) 1996-04-11
JPH0723370B2 (ja) 1995-03-15
GB8602518D0 (en) 1986-03-05
ATE129242T1 (de) 1995-11-15
GB2185982B (en) 1990-05-16
KR870007889A (ko) 1987-09-22

Similar Documents

Publication Publication Date Title
RO83401B (ro) Compozitie erbicida
ES8604564A1 (es) Procedimiento de obtencion de derivados de 4-aril-1,4-dihi- dropiridinas
DE3561817D1 (de) 5-amino-4-heterocyclyl-1-phenylpyrazoles
DK0382660T3 (da) Dioxaphosphorinanforbindelser og dermed stabiliserede polyolefinmaterialer
ATE57930T1 (de) Dihydropyridine.
DK304289D0 (da) Hidtil ukendte forbindelser
ES2078215T3 (es) 1,4-dihidropiridinas.
FI894082A0 (fi) Foerbaettringar i anslutning till polymerfoereningar.
ATE81651T1 (de) Substituierte aromatische verbindungen mit zentraler nervensystem-wirkung.
ES551421A0 (es) Un procedimiento para preparar imidazol-5-carboximidatos
EP0253502A3 (en) Tertiary amine compounds
ATE96776T1 (de) Glycinverbindungen.
FI831193A0 (fi) Organosilylfoereningar och deras anvaendning som fungicider
ATE88856T1 (de) Quaternierte stickstoffhaltige verbindungen.
DE3572483D1 (en) Carboxamide derivatives, their preparation and their use as fungicides
ES2091287T3 (es) Compuestos polimericos.
MX9201575A (es) Compuestos novedosos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 233015

Country of ref document: ES